Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies

被引：6

作者：

Collado, M

Landt, F

Barragán, E

Lass, U

Cervera, J

Sanz, MA

Bolufer, P

机构：

[1] Univ Valencia, Hosp La Fe, Escuela Enfermeria 7, Mol Biol Lab, Valencia 46007, Spain

[2] Univ Valencia, Hosp La Fe, Dept Med Biopathol, Valencia 46007, Spain

[3] Univ Valencia, Hosp La Fe, Serv Hematol, Valencia 46007, Spain

[4] TIB MOLBIOL, Berlin, Germany

来源：

CLINICAL CHEMISTRY | 2004年 / 50卷 / 11期

关键词：

D O I：

10.1373/clinchem.2004.038331

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：2201 / 2204

页数：4

共 13 条

[1] Analysis of CHK2 in patients with myelodysplastic syndromes [J].

Aktas, D ;

Arno, MJ ;

Rassool, F ;

Mufti, GJ .

LEUKEMIA RESEARCH, 2002, 26 (11) :985-987

[2] Mutations in CHEK2 associated with prostate cancer risk [J].

Dong, XY ;

Wang, L ;

Taniguchi, K ;

Wang, XS ;

Cunningham, JM ;

McDonnell, SK ;

Qian, CP ;

Marks, AF ;

Slager, SL ;

Peterson, BJ ;

Smith, BI ;

Cheville, JC ;

Blute, ML ;

Jacobsen, SJ ;

Schaid, DJ ;

Tindall, DJ ;

Thibodeau, SN ;

Liu, WG .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) :270-280

[3] The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis [J].

Falck, J ;

Mailand, N ;

Syljuåsen, RG ;

Bartek, J ;

Lukas, J .

NATURE, 2001, 410 (6830) :842-847

[4] To the editor: Mutations of Chk2 in primary hematopoietic neoplasms [J].

Hangaishi, A ;

Ogawa, S ;

Qiao, Y ;

Wang, LL ;

Hosoya, N ;

Yuji, K ;

Imai, Y ;

Takeuchi, K ;

Miyawaki, S ;

Hirai, H .

BLOOD, 2002, 99 (08) :3075-3077

[5] LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E [J].

Jacobsen, N ;

Bentzen, J ;

Meldgaard, M ;

Jakobsen, MH ;

Fenger, M ;

Kauppinen, S ;

Skouv, J .

NUCLEIC ACIDS RESEARCH, 2002, 30 (19) :e100

[6]

KENNETH O, 2003, BMC MED GENET, V4, P1

[7] Linkage of ATM to cell cycle regulation by the Chk2 protein kinase [J].

Matsuoka, S ;

Huang, MX ;

Elledge, SJ .

SCIENCE, 1998, 282 (5395) :1893-1897

[8] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].

Meijers-Heijboer, H ;

van den Ouweland, A ;

Klijn, J ;

Wasielewski, M ;

de Snoo, A ;

Oldenburg, R ;

Hollestelle, A ;

Houben, M ;

Crepin, E ;

van Veghel-Plandsoen, M ;

Elstrodt, F ;

van Duijn, C ;

Bartels, C ;

Meijers, C ;

Schutte, M ;

McGuffog, L ;

Thompson, D ;

Easton, DF ;

Sodha, N ;

Seal, S ;

Barfoot, R ;

Mangion, J ;

Chang-Claude, J ;

Eccles, D ;

Eeles, R ;

Evans, DG ;

Houlston, R ;

Murday, V ;

Narod, S ;

Peretz, T ;

Peto, J ;

Phelan, C ;

Zhang, HX ;

Szabo, C ;

Devilee, P ;

Goldgar, D ;

Futreal, PA ;

Nathanson, KL ;

Weber, BL ;

Rahman, N ;

Stratton, MR .

NATURE GENETICS, 2002, 31 (01) :55-59

[9] The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population [J].

Osorio, A ;

Rodríguez-López, R ;

Díez, O ;

de la Hoya, M ;

Martínez, JI ;

Vega, A ;

Esteban-Cardeñosa, E ;

Alonso, C ;

Caldés, T ;

Benítez, J .

INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) :54-56

[10] A robust method for detecting CHK2/RAD53 mutations in genomic DNA [J].

Sodha, N ;

Houlston, RS ;

Williams, R ;

Yuille, MA ;

Mangion, J ;

Eeles, RA .

HUMAN MUTATION, 2002, 19 (02) :173-177

← 1 2 →